Research Theme: This U54 Center will use translational research from brain to bedside as a tool for medication development in cocaine use disorder (CocUD). Preclinical and early phase I clinical PK/PD data will provide information for go/no-go decisions on phase 11-111 clinical trials for medications that have some promise for CocUD based on drug mechanisms and early preclinical data. The overall goal of this application is to create a center that can provide important preclinical and eariy phase 1 clinical data to NIDA and pharmaceutical industry partners on novel compounds for cocaine use disorder The lack of thorough characterization of compounds prior to large-scale clinical trials is least part of the reason for the large number of negative clinical trials for CocUD (Vocci and Elkashef, 2005). The initial compounds proposed for study in the center were chosen based on 1) preclinical and genetic data from our group and others supporting these classes of medications, and 2) the fact that these compounds are either available for human use currently [the selective serotonin 5-HT2C receptor (5-HT2cR) agonist lorcaserin] or are close to FDA approval [the selective serotonin 5-HT2A receptor (5-HT2AR) antagonist pimavanserin]. Lorcaserin and other 5-HT2cR agonists have been shown to reduce cocaine self-administration and cue reactivity in rodents (Project 3 Preliminary Data and (Anastasio et al, 2014a;Anastasio et al, 2014b; Cunningham et al, 2011;Manvich etal, 2012)). In addition there is human safety data in non-cocaine using subjects for lorcaserin as it is currently FDA approved for obesity, and there is safety data from a rodent cocaine interaction study (included in detail in Appendix), but there is no human cocaine interaction/PK data and no PD data to support potential dosages for phase II clinical trials. Likewise, there is evidence to support research on pimavanserin as a potential treatment for CocUD;other 5-HT2AR antagonists have been shown by our group and others to alter cocaine cue induced reinstatement in rodents (Nic Dhonnchadha etal, 2009; Pockros et al, 2011) and non-human primates (Murnane et al, 2013), but there is no specific data on pimavanserin. Finally, our group has shown that combining these two classes of compounds produces a synergistic effect on cocaine self-administration and cue reactivity (Cunningham et al, 2013) suggesting that combining these medications could produce a greater response with lower potential side effects than using either compound alone. Preclinical studies will be carried out to examine this potential combination pharmacotherapy treatment.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Virginia Commonwealth University
United States
Zip Code
Moeller, F Gerard; Cunningham, Kathryn A (2018) Innovative Therapeutic Intervention For Opioid Use Disorder. Neuropsychopharmacology 43:220-221
Conroy, Stacey C; Bjork, James M (2018) Death Ambivalence and Treatment Seeking: Suicidality in Opiate Addiction. Curr Treat Options Psychiatry 5:291-300
Johns, Sade E; Wang, Qin; Straub, Lisa K et al. (2018) Impulsivity and decision making in older and younger cocaine-dependent participants: A preliminary study. Am J Addict 27:557-559
Ma, Liangsuo; Steinberg, Joel L; Wang, Qin et al. (2017) A preliminary longitudinal study of white matter alteration in cocaine use disorder subjects. Drug Alcohol Depend 173:39-46
Neelakantan, Harshini; Holliday, Erica D; Fox, Robert G et al. (2017) Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats. ACS Chem Neurosci 8:1065-1073
Bjork, James M; Burroughs, Thomas K; Franke, Laura M et al. (2017) Rapid-Response Impulsivity Predicts Depression and Posttraumatic Stress Disorder Symptomatology at 1-Year Follow-Up in Blast-Exposed Service Members. Arch Phys Med Rehabil 98:1646-1651.e1
Azadeh, Shabnam; Hobbs, Brian P; Ma, Liangsuo et al. (2016) Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. Neuroimage 125:813-824
Bjork, James M; Burroughs, Thomas K; Franke, Laura M et al. (2016) Laboratory impulsivity and depression in blast-exposed military personnel with post-concussion syndrome. Psychiatry Res 246:321-325
Ramesh, Divya; Keyser-Marcus, Lori A; Ma, Liangsuo et al. (2015) Prevalence of traumatic brain injury in cocaine-dependent research volunteers. Am J Addict 24:341-7
Ma, Liangsuo; Steinberg, Joel L; Keyser-Marcus, Lori et al. (2015) Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study. Drug Alcohol Depend 151:128-34

Showing the most recent 10 out of 11 publications